All surgeries and chemotherapy must be completed within 42 days of study entry.No T4, N2or N3, or M1 breast cancer accepted in this trial.Treatment plan includes regional node irradiation are ineligible.Paget’s disease or the nipple and male breast cancer are ineligible.